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ABSTRACT
Ethnic differences in the risk of early-onset Hodgkin lymphoma (HL) have been understudied.
We evaluated potential associations between birth characteristics and early-onset HL in the
California Linkage Study of Early-onset Cancers, a population-based case-control study that
included a large number of non-Hispanic white and Hispanic subjects. This analysis included
2,819 HL cases (non-Hispanic white: 1651, Hispanic: 1168) diagnosed at the age of 0-37 years
in California during 1988-2015 and 140,950 controls matched on race/ethnicity and year of birth.
Odds ratios (OR) and 95% confidence intervals (CI) were estimated from multivariable logistic
regression models. Among non-Hispanic whites, a birthweight of ≥4,000g was associated with
an increased risk of HL when compared to normal birthweight (2500-3999g) (OR = 1.25, 95%
CI: 1.10, 1.43), while low birthweight (<2500g) decreased the risk (OR = 0.63, 95% CI: 0.48,
0.83). High or low birthweight did not appear to influence HL risk in Hispanics. Compared to
those with mothers born in the United States, non-Hispanic whites with mothers born outside the
United States had an increased risk of HL (OR = 1.52, 95% CI: 1.32, 1.76), but Hispanics with
mothers born outside the United States had a decreased risk of HL (OR = 0.78, 95% CI: 0.69,
0.87). Given the ethnic differences in the etiology of early-onset Hodgkin lymphoma that we
observed in this study, future research in diverse populations is warranted.
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INTRODUCTION
In the United States (US), Hodgkin lymphoma (HL) is one of the most commonly diagnosed
malignancies among children, adolescents and young adults (1-3). HL is known to have a
bimodal incidence with the incidence rising in the early teenage years, peaking in the early 20s,
and leveling off until another rise begins in the mid-40s, peaking after the age of 65 (4, 5).
Although infection with Epstein-Barr virus has been linked to HL, the etiology of HL, especially
early-onset HL, is not well understood (6-8).

The incidence of HL varies by race/ethnicity and age in the US (9, 10). Non-Hispanic whites
have a higher incidence of early-onset HL (age of diagnosis: 0-39 years) than Hispanics (3.22 per
100,000 vs. 1.79 per 100,000) (9). This difference is evident among adolescents (15-19 years)
and young adults (20-39 years), but little to no difference is seen among children (0-14 years). A
California study found that the HL incidence rate was 35% higher for those residing in lessethnic, or more acculturated, enclaves relative to those in more-ethnic enclaves among
adolescents and young adults (15-39 years), but no there were differences among children (11).
However, another California study reported that among children diagnosed at 0-5 years, Hispanic
children had a more than two-fold increased risk of HL (odds ratio [OR] = 2.43, 95% confidence
interval [CI]: 1.14, 5.17) than non-Hispanic white children (12); and compared with children of
US-born non-Hispanic white mothers, both children with US-born Hispanic mother and non-US
born Hispanic mother had increased risk of HL (13). This finding is very intriguing, but the study
was limited to HL diagnosed at the age of 0-5 years.

To investigate the etiology of early-onset HL in both Hispanics and non-Hispanic whites,
especially the role of maternal birthplace and birth characteristics more broadly, we conducted
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this analysis using data from the California Linkage Study of Early-onset Cancers (CALSEC), a
population-based case-control study with diverse race/ethnicity representation.

METHODS
Study population
The CALSEC linked California birth records from 1978-2015 to cancer cases diagnosed at the
age of 0-37 years in California during 1988-2015. Included in this analysis were first primary
non-Hispanic white and Hispanic HL cases born in California and reported to the California
Cancer Registry in 1988-2015. From a total of 2,852 HL cases identified in the CALSEC, we
excluded cases whose mother resided outside California (n=4) and cases who had unknown
maternal age (n=2), birthweight (n=1), birth order (n=18), mother’s birthplace (n=1), mode of
delivery (n=2), or status of congenital abnormalities (n=5), resulting in 2,819 cases in the final
sample.

For each case, 50 control subjects were randomly selected from the statewide birth records and
matched to the case on race/ethnicity and year of birth. The same exclusion criteria for cases
were applied to potential controls. In addition, none of the controls had been diagnosed with any
cancer based on data from the California Cancer Registry.

The study protocol was approved by the institutional review boards at all relevant institutions:
the California Health and Human Services Agency; the University of California, Berkeley; and
Yale University.

Variables of interest
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Birth characteristics and parental information were obtained from birth records. Maternal
birthplace (US or outside US) was a primary variable of interest. We also considered other
characteristics including sex, birthweight (<2500g, low; 2500-3999g, normal; 4000-7500g,
high), birth order (1st, 2nd, 3rd+ higher), gestational age (22-36, 37-41, 42-44 weeks), mode of
delivery (vaginal or caesarean), plurality (singleton or multiple), maternal history of miscarriage
or stillbirth (yes, no, or unknown), maternal age at birth (<20, 20-24, 25-29, 30-34, ≥35 years),
paternal age at birth (<20, 20-24, 25-29, 30-34, ≥35 years, or unknown), and maternal education
(less than 12 years, 12 years or more, or unknown).

Statistical analysis
Categorical variables were presented using frequencies and percentages and compared between
cases and controls using Pearson’s χ2 test. Odds ratios (ORs) and 95% confidence intervals (CIs)
were obtained from multivariable logistic regression models. Subgroup analyses were conducted
by race/ethnicity (non-Hispanic white and Hispanic) and age at diagnosis (children 0-14 years,
adolescents 15-19 years, and young adults 20-37 years). We also conducted a separate analysis
for nodular sclerosis the most common histological subtype of HL. All variables listed in Table 1
were included in the initial multivariable model and retained using the SAS stepwise function
with a p-value cutoff of 0.05. Models for different subgroup analyses sometimes retained
different sets of covariates. We chose a final list of covariates for all analyses if a variable was
retained in the model for any analysis, and the final list included sex, birthweight, birth order,
mode of delivery, maternal birthplace, maternal age, and paternal age. All analyses were
conducted in SAS (Version 9.4, SAS Institute, Cary, North Carolina) with two-sided tests and a
type I error of 5% as the threshold for statistical significance.
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RESULTS
Of the 2,819 cases, 1,651 were non-Hispanic white, and 1,168 were Hispanic. Cases and
controls were comparable in terms of year of birth and race/ethnicity on which they were
matched (Table 1). Compared to controls, cases were more likely to be male, to have higher
birthweight and to have been delivered by cesarean section. Parents of cases tended to be older
than parents of controls. No significant differences were observed between cases and controls
with regard to gestational age, birth order, birth plurality, maternal birthplace, history of
miscarriage/stillbirth, and maternal education (Table 1).

Table 1. Characteristics of the Study Population by Case-Control Status, California Linkage Study
of Early-Onset Cancers, 1988-2015.

Characteristic
Sex
Female
Male
Race/Ethnicity
Non-Hispanic White
Hispanic
Birth Year
1978-1982
1983-1987
1988-1992
1993-2009
Birth Weight (grams)
Low (250-2499)
Normal (2500-3999)
High (4000-7500)
Gestational Age (weeks)
22-36
37-41
42-44
Unknown
Birth Order
1
2
3+

Case
(N = 2819)a

Control
(N = 140950)a

1276 (45.3)
1543 (54.7)

68777 (48.8)
72173 (51.2)

1651 (58.6)
1168 (41.4)

82550 (58.6)
58400 (41.4)

Pb
<.01

1.00

1.00
744 (26.4)
760 (27.0)
722 (25.6)
593 (21.0)

37200 (26.4)
38000 (27.0)
36100 (25.6)
29650 (21.0)

123 (4.4)
2253 (79.9)
443 (15.7)

7499 (5.3)
115291 (81.8)
18160 (12.9)

231 (8.2)
2051 (72.8)
319 (11.3)
218 (7.7)

11749 (8.3)
102062 (72.4)
15938 (11.3)
11201 (8.0)

1129 (40.1)
926 (32.9)
764 (27.1)

58262 (41.3)
44551 (31.6)
38137 (27.1)

<.01

0.97

0.29
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Case
(N = 2819)a

Control
(N = 140950)a

Characteristic
Pb
Mode of Delivery
<.01
Vaginal
2159 (76.6)
111216 (78.9)
Cesarean
660 (23.4)
29734 (21.1)
Birth Plurality
0.71
Singleton
2761 (97.9)
137903 (97.8)
Multiple
58 (2.1)
3047 (2.2)
Mother’s Age at Birth
<.01
<20
227 (8.1)
15991 (11.4)
20-24
704 (25.0)
40041 (28.4)
25-29
931 (33.0)
42790 (30.4)
30-34
638 (22.6)
28787 (20.4)
35+
319 (11.3)
13341 (9.5)
Father’s Age at Birth
<.01
<20
89 (3.2)
5528 (3.9)
20-24
475 (16.9)
28413 (20.2)
25-29
831 (29.5)
40759 (28.9)
30-34
684 (24.3)
33475 (23.4)
35+
646 (22.9)
26590 (18.9)
Unknown
94 (3.3)
6185 (4.4)
Maternal Education
0.37
Less than 12 years
780 (27.7)
40147 (28.5)
Greater than 12 years
502 (17.8)
23830 (16.9)
Unknown
1537 (54.5)
76973 (54.6)
Maternal Birthplace
0.61
United States.
1963 (69.6)
98682 (70.0)
Other
856 (30.4)
42268 (30.0)
History of Miscarriage
or Stillbirth
0.60
No
2307 (81.8)
115569 (82.0)
Yes
506 (18.0)
24938 (17.7)
Unknown
6 (0.2)
443 (0.3)
a Numbers may not sum to total due to missing data, and percentages may not sum to 100% due
to rounding
b P-value

is for Chi-squared test
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A multivariable logistic regression analysis of the overall study population suggested that males
had 13% increased risk of HL (OR = 1.13, 95% CI: 1.05, 1.22) than females (Table 2). Increased
risk of HL was also observed with high birthweight (OR = 1.19, 95% CI: 1.07, 1.32) and
delivered by cesarean section (OR = 1.10, 95% CI: 1.00, 1.20). Those with a birth order of 3rd or
higher had a lower risk of HL compared to firstborns (OR = 0.87, 95% CI: 0.79, 0.97).
Compared to individuals born to mothers aged 25-29 years, those delivered by mothers at ages
20-24 years (OR = 0.82, 95% CI: 0.73, 0.91) or <20 years (OR = 0.65, 95% CI: 0.54, 0.78) also
had a decreased risk of HL (Table 2).
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Table 2. Adjusted Odds Ratios and 95% Confidence Intervals for the Risk of Early-onset Hodgkin
Lymphoma (0-37 years), California Linkage Study of Early-Onset Cancers, 1988-2015.
Characteristic
Odds Ratio 95% Confidence interval
Sex
Female
Ref
Male
1.14
1.05-1.22
Race/Ethnicity
Non-Hispanic white
Ref
Hispanic
1.10
1.00-1.21
Birth Weight (grams)
Low (250-2499)
1.19
1.07-1.32
Normal (2500-3999)
Ref
High (4000-7500)
0.83
0.69-1.00
Birth Order
1
Ref
2
0.90
0.89-1.07
3+
0.87
0.79-0.97
Mode of Delivery
Vaginal
Ref
Cesarean
1.10
1.00-1.20
Mother’s Age at Birth
<20
0.65
0.54-0.78
20-24
0.82
0.73-0.91
25-29
Ref
30-34
1.01
0.90-1.12
35+
1.04
0.89-1.20
Father’s Age at Birth
<20
1.02
0.79-1.32
20-24
0.93
0.82-1.05
25-29
Ref
30-34
0.95
0.86-1.07
35+
1.12
0.99-1.27
Unknown
0.81
0.65-1.10
Maternal Birthplace
United States
Ref
Other
0.99
0.90-1.09
All variables in the table were mutually adjusted.

Maternal birthplace showed different association with the risk of HL in the two ethnic groups.
Compared with individuals whose mothers were born in the US, those with mother born outside
the US had a 22% decreased risk of HL (OR = 0.78, 95% CI: 0.69, 0.87) among Hispanics, but a
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52% increased risk of HL (OR = 1.52, 95% CI: 1.32, 1.76) among non-Hispanic whites (Figure
1). Among Hispanics, males had an increased risk of HL (OR = 1.26, 95% CI: 1.12, 1.42) than
females; among non-Hispanic whites, sex did not appear to be associated with HL risk. Among
non-Hispanic whites, high birthweight was associated with an increased risk of HL when
compared to normal birthweight (OR = 1.25, 95% CI: 1.10, 1.43), while low birthweight had
reduced risk (OR = 0.63, 95% CI: 0.48, 0.83). In contrast, birthweight did not influence HL risk
in Hispanics. Those delivered by younger mothers had a lower risk of HL among both Hispanics
and non-Hispanic whites (Figure 1).

Figure 1. Adjusted Odds Ratios and 95% Confidence Intervals for the Risk of Early-onset
Hodgkin Lymphoma (0-37 years) by ethnicity, California Linkage Study of Early-Onset
Cancers, 1988-2015
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As maternal birthplace, sex, and birthweight showed different associations with HL in the two
ethnic groups, we conducted age-specific analyses for the two ethnic groups separately. As
shown in Figure 2, non-Hispanic whites whose mothers were born outside the US were at an
increased risk for HL among children (OR = 2.16, 95% CI: 1.60, 2.92) and young adults (OR =
1.55, 95% CI: 1.23, 1.90). Among Hispanics, a decreased risk of HL among individuals whose
mothers were born outside the US was observed among adolescents (OR = 0.76, 95% CI: 0.60,
0.95) and young adults (OR = 0.70, 95% CI: 0.58, 0.84).

Figure 2. Association between maternal birthplace and risk of Hodgkin lymphoma by age and
ethnicity, California Linkage Study of Early-Onset Cancers, 1988-2015
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Our analysis of the most common histological subtype of HL generated results that were
extremely similar to those from the analysis of HL as a single entity, so we decided not to
present the results separately.

DISCUSSION
In this large population-based case-control study, we investigated the etiology of early-onset HL,
with a focus on potential ethnic differences. Compared to those with US-born mother, among
non-Hispanic whites, children and young adults with non-US born mothers were at an increased
risk of HL; but among Hispanics, adolescents and young adults of non-US born mother had a
decrease risk of HL. The association between sex, birthweight and HL risk also exhibited ethnic
heterogeneity, supporting the possibility that non-Hispanic whites and Hispanics may have
distinct etiological profiles for HL.

Only limited studies have assessed maternal birthplace and risk of HL. A Texas study reported
no difference in risk of HL (OR = 0.87, 95% CI: 0.52, 1.44) between children with Mexicanborn mothers and those with US-born mothers (14). This study was limited to children up to 16
years and did not further stratify by ethnicity. Also, in this study, although 73 of 143 HL cases
were Hispanic, only a total of 42 (28.7%) mothers were born outside the US (14). In our study,
mothers of about 30% participants were born outside the US, with a higher percentage among
Hispanics (54.6% in cases and 60.1% in controls). Among California children aged 0-5 years,
compared with children of non-Hispanic white mothers, children with US-born Hispanic mothers
(OR = 2.49, 95% CI: 1.21, 5.13) or non-US born Hispanic mothers (OR = 2.35, 95% CI: 1.24,
4.47) both had increased risk of HL (13). As HL is rare among young children, this study only

16
included a total of 66 HL cases and did not specifically evaluate the role of maternal birthplace
among Hispanics (13).

The mechanism underlying the association between maternal birthplace and risk of HL is
challenging to fathom. The influence of the Hispanic paradox and stress of immigration are seen
in many aspects of life and health, ranging from cancer to mental health and beyond (13, 15-17).
How this paradox might play a role in early-onset cancer, particularly for children and
adolescents is unclear. It is known that in general, as Hispanic people immigrate to the US their
diets and behaviors gradually shift to those common to the US, and their health may decline (18,
19). One recent study found that as acculturation increased for migrant mothers to the US, so did
the number of adverse pregnancy outcomes reported (20). Furthermore, another study revealed
that when comparing native and migrant populations in Spain, the natives were more likely to
develop chronic conditions and cancer in adulthood (21). These findings support the current
view that both genetic and environmental factors play a role in the etiology of HL (22, 23).

Our finding on the higher risk of HL among male children was consistent with sex-specific
incidence rates observed in the Surveillance, Epidemiology and End Results (SEER) program.
Williams et al. calculated the incidence rate ratio for HL using data from SEER 18 (2000-2015)
and showed that male sex was associated with a higher rate than female sex (incidence rate ratio
= 1.25, 95% CI: 1.20, 1.30) (24). We also observed an increased risk of HL among those with
high birthweight which was consistent with our previous findings in the pediatric population
(25). Similarly, a Swedish study reported that high fetal growth was associated with an
increased risk of HL among those age 0-37 years (26). However, other studies have found no
relationship between birthweight and childhood HL (12, 27-30). Given the ethnic differences we
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observed in the association between sex, birthweight and the risk of HL, it would be important to
conduct more etiological studies of HL in racially/ethnically diverse populations and
accommodate potential ethnic disparity in statistical analysis. In our study, higher birth order was
associated with decreased risk of HL, especially among adolescents and young adults. Findings
from a Danish study suggested that increasing birth order increased the relative risk of childhood
HL (0-14 years) but decreased the relative risk of HL in young adults (≥15 years) (31, 32).
Nevertheless, other studies have found no association between birth order and risk of HL (14, 26,
33, 34). Possible explanations for the inconsistent findings might include the varying ages of HL
diagnosis included in different studies and the relatively small sample sizes in many existing
studies. For example, only one of these studies has an age range of 1-37 years (26), while the
others are more varied, ranging from 0-16 years to 15 years and older (14, 33, 34). The largest
sample size from these studies is 943 cases, with the others all falling below 400.

Our study has several limitations. Firstly, the CALSEC linkage consisted of birth records from
1978 (when California birth records first became computerized) and cancer diagnoses from 1988
(when the statewide cancer reporting was fully implemented). All cases had to be born in
California, which accounted for 61% of all HL cases diagnosed at the age of 0-37 years and
reported to the California Cancer Registry (the coverage is 77.2% for HL in children). However,
there is no reason to believe that HL cases diagnosed in California but not born there have a
systematically different etiology. Alternatively, our design can be conceptualized as a casecohort study, in which we identified cases from a cohort consisting of all California births.
Second, there was potential for misclassification of controls who might have moved out of
California and been diagnosed with early-onset HL elsewhere. Based on the age-specific
incidence rate of HL in California from 2000-2015, we estimate that 35 out of 140,950 controls
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would have developed HL by the age of 37 years if they had all moved out of California the day
after birth. Lastly, we were limited to data available in existing records, and therefore could not
adjust for additional risk factors for HL such as history of Epstein-Barr virus infection or
infectious mononucleosis (6-8, 35-37).

The study also has multiple strengths. The large size and racial/ethnic diversity of the California
population resulted in a large number of non-Hispanic white and Hispanic cases, and we also had
access to 50 times as many controls, which helped to improve statistical power and allowed us to
conduct stratified analyses by ethnicity and age of diagnosis (children, adolescents, and young
adults). Previous studies on the etiology of HL have mostly been conducted in
European/Caucasian populations, so the analysis of HL risk factors among Hispanics is a major
strength of our study. The CALSEC is record linkage-based which obviated the need for
participant contact and therefore we were able to obtain preexisting, non-identifying data without
active consent. As a result, this study was less prone to selection bias due to non-participation
due to differential recall between cases and controls.

CONCLUSION
In summary, this large population-based case-control study identified multiple risk factors for
HL in children, adolescents, and young adults from California. Compared to individuals with
US-born mothers, among Hispanics, children and young adults with non-US born mothers were
at an increased risk of HL; but among non-Hispanic whites, adolescents and young adults of nonUS born mother had a decrease risk of HL. The association between sex, birthweight and HL risk
also varied by ethnicity. These findings underscore the importance of accounting for potential
ethnic differences in the etiology of early-onset HL in future studies.
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